Inflammatory Bowel Disease (IBD) Cutting Edge 2026: Where Innovation, Trials, and Multidisciplinary Care Intersect

Inflammatory Bowel Disease (IBD) Cutting Edge 2026: Where Innovation, Trials, and Multidisciplinary Care Intersect is organized by Scripps Health and will be held from Sep 11 - 13, 2026 at Hyatt Regency Mission Bay Spa and Marina, San Diego, California, United States of America.

Description:
The IBD Cutting Edge 2026 conference will showcase pioneering advancements in translational science, drug discovery, and clinical care for inflammatory bowel disease (IBD). The program will highlight the evolving landscape of clinical trials, innovative therapeutic strategies, and the complexities of managing IBD in diverse patient groups. Key topics will cover disease-specific complications, care considerations for special populations, the role of surgery in IBD management, and the integration of multidisciplinary approaches to enhance treatment outcomes.

Additionally, the conference will introduce emerging technologies, patient-centered care initiatives, and discussions on ensuring equity in access to care. Attendees will benefit from lectures and interactive sessions led by both international and national key opinion leaders in IBD. The comprehensive program will provide health care professionals with actionable insights to optimize patient care, advance clinical practices, and improve the quality of life for those living with IBD.

NEW THIS YEAR! An engaging hands-on Intestinal Ultrasound Workshop will be offered on Friday as a complement to the main conference. This immersive workshop will offer a unique opportunity to learn and refine ultrasound techniques for assessing inflammatory bowel disease (IBD) under the guidance of world-renowned experts. Gain practical skills in utilizing this non-invasive, real-time imaging modality to enhance diagnosis, monitor disease activity, and optimize patient care. Whether you're a beginner or looking to advance your expertise, this workshop is designed to elevate your clinical practice and keep you at the cutting edge of IBD management.

Objectives:
Upon completion of this activity, participants should be able to:

1. Explore Translational Science: Describe how emerging insights from translational research are shaping novel therapeutic approaches for inflammatory bowel disease (IBD).
2. Analyze Clinical Trial Innovations: Evaluate findings from recent and ongoing clinical trials to inform the development and application of next-generation therapies for IBD.
3. Integrate Multidisciplinary Care Strategies: Identify opportunities to optimize patient outcomes through collaborative care models involving gastroenterologists, surgeons, dietitians, psychologists, and other specialists.
4. Implement Advanced Surgical and Medical Approaches: Assess the latest advancements in surgical interventions and medical therapies, including their roles in treating complex IBD cases.
5. Address Challenges in Special Populations: Examine the unique treatment considerations for pediatric, adolescent, and high-risk IBD populations, ensuring equitable and personalized care.
6. Foster Patient-Centered Care: Develop approaches that emphasize shared decision-making and improved quality of life for patients living with IBD.